A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Kim, Yuseob ^a   Escalante, Ananias A ^b   Schneider, Kristan A ^c  

^a Ewha Womans University   (South Korea)

^b Arizona State University   (United States)

^c UNIVERSITY OF APPLIED SCIENCES MITTWEIDA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; DRUG EFFICACY; DRUG TREATMENT FAILURE; GROWTH RATE; HAPLOTYPE; HOST PARASITE INTERACTION; HUMAN; INTRASPECIFIC COMPETITION; MALARIA; MICROBIAL GROWTH; MICROBIAL POPULATION DYNAMICS; MULTIPLE CYCLE TREATMENT; MUTATION RATE; NONHUMAN; PARASITE CLEARANCE; PARASITE TRANSMISSION; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); POPULATION GENETICS; REPRODUCTIVE FITNESS; ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; DISEASE CARRIER; DRUG COMBINATION; DRUG RESISTANCE; GENE; GENETICS; MALARIA, FALCIPARUM; MOSQUITO; PARASITOLOGY; PLASMODIUM FALCIPARUM; POISSON DISTRIBUTION; STATISTICS; TRANSMISSION;

ANIMALS; ANTIMALARIALS; COMPUTER SIMULATION; CULICIDAE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GENES, PROTOZOAN; GENETICS, POPULATION; HOST-PARASITE INTERACTIONS; HUMANS; INSECT VECTORS; MALARIA, FALCIPARUM; MODELS, GENETIC; MUTATION RATE; PLASMODIUM FALCIPARUM; POISSON DISTRIBUTION; STOCHASTIC PROCESSES;

EID: 84903976096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101601     Document Type: Article

References (44)

1. Curtis CF, Otoo LN (1986) A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene 80: 889-892. (Pubitemid 17220686)
2. Payne D (1987) Spread of chloroquine resistance in Plasmodium falciparum. Parasitology today 3: 241-246.
3. Klein E (2013) Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread. International journal of antimicrobial agents 41: 311-317.
4. Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, et al. (2003) A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Molecular Biology and Evolution 20: 1526-1536. (Pubitemid 37082588)
5. McCollum AM, Schneider KA, Griffing SM, Zhou Z, Kariuki S, et al. (2012) Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya. Malar J 11: 77.
6. McCollum AM, Mueller K, Villegas L, Udhayakumar V, Escalante AA (2007) Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrobial agents and chemotherapy 51: 2085-2091. (Pubitemid 46903098)
7. Peters W (1990) The prevention of antimalarial drug resistance. Pharmacology & therapeutics 47: 499-508.
8. White NJ (1998) Preventing antimalarial drug resistance through combinations. Drug resistance updates 1: 3-9.
9. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine 361: 455-467.
10. Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, et al. (2010) Artemisinin resistance: current status and scenarios for containment. Nature Reviews Microbiology 8: 272-280.
11. Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, et al. (2012) A major genome region underlying artemisinin resistance in malaria. Science 336: 79-82.
12. Miotto O, Almagro-Garcia J, Manske M, MacInnis B, Campino S, et al. (2013) Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nature genetics.
13. Na-Bangchang K, Karbwang J (2013) Emerging artemisinin resistance in the border areas of Thailand. Expert review of clinical pharmacology 6: 307-322.
14. Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, et al. (2013) Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proceedings of the National Academy of Sciences 110: 240-245.
15. Schneider KA, Kim Y (2010) An analytical model for genetic hitchhiking in the evolution of antimalarial drug resistance. Theoretical population biology 78: 93-108.
16. Mackinnon MJ (2005) Drug resistance models for malaria. Acta tropica 94: 207-217.
17. Koella JC, Antia R (2003) Epidemiological models for the spread of antimalarial resistance. Malaria Journal 2: 3.
18. Escalante AA, Smith DL, Kim Y (2009) The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum. Trends in parasitology 25: 557-563.
19. Dye C (1991) Population genetics of nonclonal, nonrandomly mating malaria parasites. Parasitology Today 7: 236-240.
20. Dye C, Williams BG (1997) Multigenic drug resistance among inbred malaria parasites. Proceedings of the Royal Society of London Series B: Biological Sciences 264: 61.
21. Hastings IM (1997) A model for the origins and spread of drug-resistant malaria. Parasitology 115: 133-141.
22. Hastings IM, Mackinnon MJ (1998) The emergence of drug-resistant malaria. Parasitology 117: 411-417. (Pubitemid 28505763)
23. Mackinnon M, Hastings I (1998) The evolution of multiple drug resistance in malaria parasites. Transactions of the Royal Society of Tropical Medicine and Hygiene 92: 188-195. (Pubitemid 28202428)
24. Hastings IM, D'Alessandro U (2000) Modelling a Predictable Disaster: The Rise and Spread of Drug-resistant Malaria. Parasitology Today 16: 340-347. (Pubitemid 30460031)
25. Antao T, Hastings I (2011) Environmental, pharmacological and genetic influences on the spread of drug-resistant malaria. Proceedings of the Royal Society B: Biological Sciences 278: 1705-1712.
26. Pongtavornpinyo W, Hastings IM, Dondorp A, White LJ, Maude RJ, et al. (2009) Probability of emergence of antimalarial resistance in different stages of the parasite life cycle. Evolutionary applications 2: 52-61.
27. Hayton K, Su X (2008) Drug resistance and genetic mapping in Plasmodium falciparum. Current genetics 54: 223-239.
28. Hedrick PW (2011) Genetics of populations: Jones & Bartlett.
29. Gatton ML, Cheng Q (2002) Evaluation of the pyrogenic threshold for Plasmodium falciparum malaria in naive individuals. American Journal of Tropical Medicine and Hygiene 66: 467-473.
30. White NJ (2004) Antimalarial drug resistance. Journal of Clinical Investigation 113: 1084-1092.
31. WHO (2010) Guidlines for the treatment of malaria. 2nd ed. Geneva: World Health Organization. pp. Available: http://www.who.int/malaria/publications/ atoz/9789241547925/en/index.html.
32. Ellegren H (2009) A selection model of molecular evolution incorporating the effective population size. Evolution 63: 301-305.
33. Huijben S, Nelson WA, Wargo AR, Sim DG, Drew DR, et al. (2010) Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasistes. Evolution 64: 2952-2968.
34. Read AF, Day T, Huijben S (2011) The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proceedings of the National Academy of Sciences 108: 10871.
35. Wargo AR, Huijben S, de Roode JC, Shepherd J, Read AF (2007) Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proceedings of the National Academy of Sciences 104: 19914-19919.
36. Roper C, Pearce R, Nair S, Sharp B, Nosten F, et al. (2004) Intercontinental spread of pyrimethamine-resistant malaria. Science 305: 1124. (Pubitemid 39100317)
37. Hastings I (2004) The origins of antimalarial drug resistance. Trends in Parasitology 20: 512-518.
38. Hastings I (2011) How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance. Trends in Parasitology 27: 67-72.
39. Bousema T, Drakeley C (2011) Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clinical microbiology reviews 24: 377-410.
40. Churcher TS, Bousema T, Walker M, Drakeley C, Schneider P, et al. (2013) Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. Elife 2: e00626.
41. REX Consortium (2013) Heterogeneity of selection and evolution of resistance. Trends in Ecology and Evolution 28: 111-118.
42. Hastings IM, Watkins WM, White NJ (2002) The evolution of drug-resistant malaria: the role of drug elimination half-life. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences 357: 505-519. (Pubitemid 34489862)
43. Klein EY (2014) The impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance. Journal of theoretical biology 340: 177-185.
44. White N, Pongtavornpinyo W (2003) The de novo selection of drug-resistant malaria parasites. Proceedings of the Royal Society of London Series B: Biological Sciences 270: 545-554. (Pubitemid 36308233)